Clinical Trial

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

Study acronym: Cr
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate whether oral chromium supplementation can decrease steroid-induced hyperglycemia in diabetic patients undergoing ultrasound-guided sacroiliac joint injections through a randomized controlled trial (RCT).
Trial Details
NCT Number NCT06709313
Lead Sponsor Fayoum University
Conditions Sacro Iliac Joint Pain, Diabetes
Enrollment 60 participants
Start Date 2024-06-03
Primary Completion 2025-01 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-29